Increased and mistimed sex hormone production in night shift workers

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 5, 2015, Pages 854-863

  Papantoniou, Kyriaki ^a,b,c,d   Pozo, Oscar J ^b   Espinosa, Ana ^a,b,c,d   Marcos, Josep ^b,c   Castaño Vinyals, Gemma ^a,b,c,d   Basagaña, Xavier ^a,b,c,d   Pagès, Elena Juanola ^e   Mirabent, Joan ^c,f   Martín, Jordi ^e   Faro, Patricia Such ^g   Aparici, Amparo Gascó ^h   Middleton, Benita ⁱ   Skene, Debra J ⁱ   Kogevinas, Manolis ^a,b,c,d,j  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e GENERALITAT DE CATALUNYA   (Spain)

^f Occupational Health Service   (Spain)

^g Seat SA   (Spain)

^h HOSPITAL DE VILADECANS   (Spain)

ⁱ UNIVERSITY OF SURREY   (United Kingdom)

^j NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

more..

Author keywords

[No Author keywords available]

Indexed keywords

16 ANDROSTENOL; 3ALPHA,5ALPHA ANDROSTANEDIOL; 3ALPHA,5BETA ANDROSTANEDIOL; 6 HYDROXYMELATONIN O SULFATE; 6ALPHA HYDROXY ANDROSTENEDIONE; ANDROGEN; ANDROSTENEDIONE; ANDROSTERONE; EPITESTOSTERONE; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; ETIOCHOLANOLONE; GESTAGEN; MELATONIN; PREGNANEDIOL; PREGNANETRIOL; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG; 6-SULFATOXYMELATONIN;

ADULT; ARTICLE; FEMALE; HORMONE SYNTHESIS; HUMAN; INDUSTRIAL WORKER; MAJOR CLINICAL STUDY; MALE; NIGHT SHIFT WORKER; NURSE; PRIORITY JOURNAL; SEX DIFFERENCE; SHIFT WORKER; URINALYSIS; URINE LEVEL; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; CIRCADIAN RHYTHM; MIDDLE AGED; PHYSIOLOGY; PROSTATIC NEOPLASMS; URINE; WORK SCHEDULE; YOUNG ADULT;

ADULT; ANDROGENS; BREAST NEOPLASMS; CIRCADIAN RHYTHM; ESTROGENS; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; PROGESTINS; PROSTATIC NEOPLASMS; WORK SCHEDULE TOLERANCE; YOUNG ADULT;

EID: 84965167010     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-1271     Document Type: Article

References (58)

1. IARC. Painting, Firefighting and Shiftwork IARC Monographs Vol 98. Lyon, France: International Agency for Research on Cancer (IARC); 2010. http://monographs.iarc.fr
2. Ijaz S, Verbeek J, Seidler A, Lindbohm ML, Ojajarvi A, Orsini N, et al. Nightshift work and breast cancer-a systematic review and meta-analysis. Scand J Work Environ Health 2013;39:431-47.
3. Jia Y, Lu Y, Wu K, Lin Q, Shen W, Zhu M, et al. Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiol 2013;37:197-206.
4. Papantoniou K, Kogevinas M. Shift work and breast cancer: do we need more evidence and what should this be? Occup Environ Med 2013;70:825-6.
5. Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, et al. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2012;21:1002-11.
6. Papantoniou K, Castano-Vinyals G, Espinosa A, Aragones N, Perez-Gomez B, Burgos J, et al. Night shift work, chronotype and prostate cancer risk in the MCC-Spain case-control study. Int J Cancer 2014 Dec. 20. [Epub ahead of print].
7. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res 2007;67:10618-22.
8. Costa G, Haus E, Stevens R. Shift work and cancer - considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health 2010;36:163-79.
9. Fritschi L, Glass DC, Heyworth JS, Aronson K, Girschik J, Boyle T, et al. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses 2011;77:430-6.
10. Stevens RG. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol 2009;38:963-70.
11. Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 1987;125:556-61.
12. Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 2004;13:936-43.
13. Karatsoreos IN, Silver R. Minireview: The neuroendocrinology of the suprachiasmatic nucleus as a conductor of body time in mammals. Endocrinology 2007;148:5640-7.
14. Ota T, Fustin JM, Yamada H, Doi M, Okamura H. Circadian clock signals in the adrenal cortex. Mol Cell Endocrinol 2012;349:30-7.
15. Nagata C, Nagao Y, Yamamoto S, Shibuya C, Kashiki Y, Shimizu H. Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol Biomarkers Prev 2008;17:1418-23.
16. Gomez-Acebo I, Dierssen-Sotos T, Papantoniou K, Garcia-Unzueta MT, Santos-Benito MF, Llorca J. Association between exposure to rotating night shift versus day shift using levels of 6-sulfatoxymelatonin and cortisol and other sex hormones in women. Chronobiol Int 2015;32:128-35.
17. Alvarez-Garcia V, Gonzalez A, Martinez-Campa C, Alonso-Gonzalez C, Cos S. Melatonin modulates aromatase activity and expression in endothelial cells. Oncol Rep 2013;29:2058-64.
18. Cos S, Martinez-Campa C, Mediavilla MD, Sanchez-Barcelo EJ. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J Pineal Res 2005;38:136-42.
19. Graham C, Cook MR, Gerkovich MM, Sastre A. Examination of the melatonin hypothesis in women exposed at night to EMF or bright light. Environ Health Perspect 2001;109:501-7.
20. Langley AR, Graham CH, Grundy AL, Tranmer JE, Richardson H, Aronson KJ. Across-sectional study ofbreast cancer biomarkers among shift working nurses. BMJ Open 2012;2:e000532.
21. Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J Pineal Res 2006;40:116-24.
22. Brisken C. Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer 2013;13:385-96.
23. Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol 2007;106:24-30.
24. Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 2013;14:1009-19.
25. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976;4:97-110.
26. Van Renterghem P, Van Eenoo P, Van Thuyne W, Geyer H, Schanzer W, Delbeke FT. Validation of an extended method for the detection of the misuse of endogenous steroids in sports, including new hydroxylated metabolites. J Chromatogr B Analyt Technol Biomed Life Sci 2008;876:225-35.
27. Aldhous ME, Arendt J. Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann Clin Biochem 1988;25(Pt 3):298-303.
28. Mikulich SK, Zerbe GO, Jones RH, Crowley TJ. Comparing linear and nonlinear mixed model approaches to cosinor analysis. Stat Med 2003;22:3195-211.
29. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65.
30. Zhang X, Tworoger SS, Eliassen AH, Hankinson SE. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat 2013;137:883-92.
31. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005;12:1071-82.
32. Page JH, Colditz GA, Rifai N, Barbieri RL, Willett WC, Hankinson SE. Plasma adrenal androgens and risk of breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev 2004;13:1032-6.
33. Schernhammer ES, Sperati F, Razavi P, Agnoli C, Sieri S, Berrino F, et al. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort. Breast Cancer Res 2013;15:R46.
34. Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008;100:170-83.
35. Fuhrman BJ, Schairer C, Gail MH, Boyd-Morin J, Xu X, Sue LY, et al. Estrogen metabolism and risk of breast cancerinpostmenopausal women. J Natl Cancer Inst 2012;104:326-39.
36. Davis S, Mirick DK, Chen C, Stanczyk FZ. Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev 2012;21:609-18.
37. Wada K, Nagata C, Nakamura K, Iwasa S, Shiraki M, Shimizu H. Light exposure at night, sleep duration and sex hormone levels in pregnant Japanese women. Endocr J 2012;59:393-8.
38. Kripke DF, Elliott JA, Youngstedt SD, Parry BL, Hauger RL, Rex KM. Weak evidence of bright light effects on human LH and FSH. J Circadian Rhythms 2010;8:5.
39. Papantoniou K, Pozo O, Espinosa A, Marcos J, Castano-Vinyals G, Basagana X, et al. Circadian variation of melatonin, light exposure and diurnal preference in day and night shift workers of both sexes. Cancer Epidemiol Biomarkers Prev 2014;23:1176-86.
40. Cos S, Gonzalez A, Martinez-Campa C, Mediavilla MD, Alonso-Gonzalez C, Sanchez-Barcelo EJ. Melatonin as a selective estrogen enzyme modulator. Curr Cancer Drug Targets 2008;8:691-702.
41. Kripke DF, Kline LE, Shadan FF, Dawson A, Poceta JS, Elliott JA. Melatonin effects on luteinizinghormone in postmenopausal women: a pilot clinical trial NCT00288262. BMC Womens Health 2006;6:8.
42. Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuro Endocrinol Lett 2002;23 Suppl 1:17-9.
43. Schernhammer ES, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, et al. A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers. Cancer Causes Control 2013;23:609-16.
44. Siegrist C, Benedetti C, Orlando A, Beltran JM, Tuchscherr L, Noseda CM, et al. Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle-aged, and elderly patients. J Pineal Res 2001;30:34-42.
45. Voordouw BC, Euser R, Verdonk RE, Alberda BT, De Jong FH, Drogendijk AC, et al. Melatonin and melatonin-progestin combinations alter pituitaryovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab 1992;74:108-17.
46. Fernandez B, Malde JL, Montero A, Acuna D. Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women. J Steroid Biochem 1990;35:257-62.
47. Okatani Y, Morioka N, Wakatsuki A. Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations. J Pineal Res 2000;28:111-8.
48. Vakkuri O, Kivela A, Leppaluoto J, Valtonen M, Kauppila A. Decrease in melatonin precedes follicle-stimulating hormone increase during perimenopause. Eur J Endocrinol 1996;135:188-92.
49. Clark ML, Burch JB, Yost MG, Zhai Y, Bachand AM, Fitzpatrick CT, et al. Biomonitoring of estrogen and melatonin metabolites among women residing near radio and television broadcasting transmitters. J Occup Environ Med 2007;49:1149-56.
50. Cooke RR, McIntosh JE, McIntoshRP. Circadianvariationinserum free and non-SHBG-bound testosterone in normal men: measurements, and simulation using a mass action model. Clin Endocrinol 1993;39:163-71.
51. Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol 2003;58:710-7.
52. Hucklebridge F, Hussain T, Evans P, Clow A. The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology 2005;30:51-7.
53. Lonning PE, Dowsett M, Jacobs S, Schem B, Hardy J, Powles TJ. Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women. J Steroid Biochem 1989;34:551-3.
54. Jerjes WK, Cleare AJ, Peters TJ, Taylor NF. Circadian rhythm of urinary steroid metabolites. Ann Clin Biochem 2006;43:287-94.
55. Arendt J. Shift work: coping with the biological clock. Occup Med (Lond) 2010;60:10-20.
56. Axelsson J, Ingre M, Akerstedt T, Holmback U. Effects of acutely displaced sleep on testosterone. J Clin Endocrinol Metab 2005;90:4530-5.
57. Wittert G. The relationship between sleep disorders and testosterone. Curr Opin Endocrinol Diabetes Obes 2014;21:239-43.
58. Burch JB, Yost MG, Johnson W, Allen E. Melatonin, sleep, and shift work adaptation. J Occup Environ Med 2005;47:893-901.